These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33653596)

  • 1. Autoantibody Signatures as a Biomarker Panel for the Detection of Nasopharyngeal Carcinoma.
    Shi QP; Wang X; Liu ZX; Zhang JJ; Wang ZY
    Arch Med Res; 2021 Aug; 52(6):620-626. PubMed ID: 33653596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibody Signatures Combined with Epstein-Barr Virus Capsid Antigen-IgA as a Biomarker Panel for the Detection of Nasopharyngeal Carcinoma.
    Peng YH; Xu YW; Huang LS; Zhai TT; Dai LH; Qiu SQ; Yang YS; Chen WZ; Zhang LQ; Li EM; Xu LY
    Cancer Prev Res (Phila); 2015 Aug; 8(8):729-36. PubMed ID: 25990085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of autoantibodies against NY-ESO-1 and viral capsid antigen immunoglobulin A for improved detection of nasopharyngeal carcinoma.
    Peng YH; Xu YW; Qiu SQ; Hong CQ; Zhai TT; Li EM; Xu LY
    Oncol Lett; 2014 Sep; 8(3):1096-1102. PubMed ID: 25120665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of circulating EBV microRNA BART2-5p in facilitating early detection and screening of nasopharyngeal carcinoma.
    Jiang C; Chen J; Xie S; Zhang L; Xiang Y; Lung M; Kam NW; Kwong DL; Cao S; Guan XY
    Int J Cancer; 2018 Dec; 143(12):3209-3217. PubMed ID: 29971780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of two microRNA signatures in whole blood as novel biomarkers for diagnosis of nasopharyngeal carcinoma.
    Wen W; Mai SJ; Lin HX; Zhang MY; Huang JL; Hua X; Lin C; Long ZQ; Lu ZJ; Sun XQ; Liu SL; Yang Q; Zhu Q; Wang HY; Guo L
    J Transl Med; 2019 Jun; 17(1):186. PubMed ID: 31159814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibody detection to tumor-associated antigens of P53, IMP1, P16, cyclin B1, P62, C-myc, Survivn, and Koc for the screening of high-risk subjects and early detection of esophageal squamous cell carcinoma.
    Zhou SL; Yue WB; Fan ZM; Du F; Liu BC; Li B; Han XN; Ku JW; Zhao XK; Zhang P; Cui J; Zhou FY; Zhang LQ; Fan XP; Zhou YF; Zhu LL; Liu HY; Wang LD
    Dis Esophagus; 2014; 27(8):790-7. PubMed ID: 24147952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.
    Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J
    Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNAs derived from circulating small extracellular vesicles as diagnostic biomarkers for nasopharyngeal carcinoma.
    Jiang L; Zhang Y; Li B; Kang M; Yang Z; Lin C; Hu K; Wei Z; Xu M; Mi J; Wang R; Wu F
    Cancer Sci; 2021 Jun; 112(6):2393-2404. PubMed ID: 33728743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic markers for noninvasive early detection of nasopharyngeal carcinoma by methylation-sensitive high resolution melting.
    Yang X; Dai W; Kwong DL; Szeto CY; Wong EH; Ng WT; Lee AW; Ngan RK; Yau CC; Tung SY; Lung ML
    Int J Cancer; 2015 Feb; 136(4):E127-35. PubMed ID: 25196065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case-Control Study: Smoking History Affects the Production of Tumor Antigen-Specific Antibodies NY-ESO-1 in Patients with Lung Cancer in Comparison with Cancer Disease-Free Group.
    Myšíková D; Adkins I; Hradilová N; Palata O; Šimonek J; Pozniak J; Kolařík J; Skallová-Fialová A; Špíšek R; Lischke R
    J Thorac Oncol; 2017 Feb; 12(2):249-257. PubMed ID: 27793776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Randomized Controlled Trial on Evaluation of Plasma Epstein-Barr Virus Biomarker for Early Diagnosis in Patients With Nasopharyngeal Carcinoma.
    Liu W; Li H; Sheng H; Liu X; Chi P; Wang X; Mao M
    Adv Ther; 2020 Oct; 37(10):4280-4290. PubMed ID: 32780356
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Lyu JY; Chen JY; Zhang XJ; Zhang MW; Yu GS; Zhang L; Wen Z
    Dis Markers; 2020; 2020():7253531. PubMed ID: 32454907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rta-IgG as a biomarker for diagnosis and post treatment prognostic of nasopharyngeal carcinoma.
    Xu XF; Lu RQ; Xiao R; Zhou L; Zhao XM; Hu XC; Gao X; Guo L
    Cancer Biomark; 2016; 16(3):467-76. PubMed ID: 27062704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokine CCL27 is a novel plasma biomarker for identification the nasopharyngeal carcinoma patients from the Epstein-Barr virus capsid antigen-specific IgA seropositive population.
    Mao MJ; Xue N; Wang XP; Chi PD; Liu YJ; Huang Q; Dai SQ; Liu WL
    BMC Cancer; 2018 Jan; 18(1):9. PubMed ID: 29295705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancers.
    Oshima Y; Shimada H; Yajima S; Nanami T; Matsushita K; Nomura F; Kainuma O; Takiguchi N; Soda H; Ueda T; Iizasa T; Yamamoto N; Yamamoto H; Nagata M; Yokoi S; Tagawa M; Ohtsuka S; Kuwajima A; Murakami A; Kaneko H
    J Gastroenterol; 2016 Jan; 51(1):30-4. PubMed ID: 25906289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma.
    Xu YW; Chen H; Guo HP; Yang SH; Luo YH; Liu CT; Huang XY; Tang XM; Hong CQ; Li EM; Xu LY; Peng YH
    Gastric Cancer; 2019 May; 22(3):546-557. PubMed ID: 30426295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low expression of Cyfip1 may be a potential biomarker in nasopharyngeal carcinoma.
    Shi X; Chen X; Li WC; Mo LJ; Lin ZY; Li YY; Yang Z; Mo WN
    Neoplasma; 2018; 65(2):292-295. PubMed ID: 29534591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA expression profiling analysis in serum for nasopharyngeal carcinoma diagnosis.
    Zou X; Zhu D; Zhang H; Zhang S; Zhou X; He X; Zhu J; Zhu W
    Gene; 2020 Feb; 727():144243. PubMed ID: 31743768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiparametric Detection of Antibodies against Different EBV Antigens to Predict Risk for Nasopharyngeal Carcinoma in a High-Risk Population of China.
    Chen H; Chen S; Lu J; Wang X; Li J; Li L; Fu J; Scheper T; Meyer W; Peng YH; Liu W
    Cancer Prev Res (Phila); 2017 Sep; 10(9):542-550. PubMed ID: 28754665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Epstein-Barr Virus Serological Tools for the Screening and Risk Assessment of Nasopharyngeal Carcinoma: a Large Population-based Study.
    Guo J; Cui Z; Zheng Y; Li X; Chen Y
    Pathol Oncol Res; 2020 Oct; 26(4):2185-2190. PubMed ID: 32222897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.